Buprenorphine-induced respiratory depression and involvement of ABCB1 SNPs in opioid-induced respiratory depression in paediatrics

By Niesters M.   Overdyk F.   Smith T.   Aarts L.   Dahan A.  

BJA: British Journal of Anaesthesia, Vol. 110, Iss. 5, 2013-05 ,pp. : 842-843

Oxford University Press

Access to resources Recommend Favorite

Risk Predictors of Opioid‐Induced Critical Respiratory Events in Children: Naloxone Use as a Quality Measure of Opioid Safety

By  

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 2139-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite

P-glycoprotein should be considered as an additional factor contributing to opioid-induced respiratory depression in paediatrics: the buprenorphine example

By Mégarbane B.   Alhaddad H.  

BJA: British Journal of Anaesthesia, Vol. 110, Iss. 5, 2013-05 ,pp. : 842-842

Oxford University Press

Access to resources Recommend Favorite

Reversal of opioid‐induced respiratory depression by BK‐channel blocker GAL021: A pharmacokinetic‐pharmacodynamic modeling study in healthy volunteers

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 641-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Root Cause Analysis of Serious Adverse Events Among Older Patients in the Veterans Health Administration

By Lee Alexandra   Mills Peter D.   Neily Julia   Hemphill Robin R.  

Joint Commission Journal on Quality and Patient Safety, Vol. 40, Iss. 6, 2014-06 ,pp. : 253-262

Joint Commission Resources

Access to resources Recommend Favorite